Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|4|5|429-434

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.5, 2004-09, pp. : 429-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerase I-DNA Complex Stability Induced by Camptothecins and Its Role in Drug Activity#

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 4, 2004-07 ,pp. : 327-334

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Cycle Effects of the Novel Topoisomerase I Inhibitor NU/ICRF 505 in a Panel of Chinese Hamster Ovary Cell Lines

By Macpherson J.S.   Cummings J.   Meikle I.   Miller E.P.   Smyth J.F.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 280-283

Elsevier

Access to resources Recommend Favorite

DNA Damaging and Cell Cycle Effects of the Topoisomerase I Poison Camptothecin in Irradiated Human Cells

By Falk S.J.   Smith P.J.  

International Journal of Radiation Biology, Vol. 61, Iss. 6, 1992-06 ,pp. : 749-757

Informa Healthcare

Access to resources Recommend Favorite

Topoisomerase I Inhibitors and Other New Cytotoxic Drugs

By Verweij J.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 828-830

Elsevier

Access to resources Recommend Favorite

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

By Vassal G.   Pondarre C.   Cappelli C.   Terrier-Lacombe M.J.   Boland I.   Morizet J.   Benard J.   Venuat A.M.   Ardouin P.   Hartmann O.   Gouyette A.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2011-2015

Elsevier

Access to resources Recommend Favorite